Personal information

Other IDs

Scopus Author ID: 57207254060

Activities

Collapse all

Employment (1)

The University of Texas at Austin: San Antonio, TX, US

2023-07-01 to present | Clinical Assistant Professor (Pharmacotherapy)
Employment
Source: Self-asserted source
Travis J. Carlson

Education and qualifications (2)

Board of Pharmacy Specialties: San Antonio, TX, US

2019-12-31 to present | BCIDP
Qualification
Source: Self-asserted source
Travis J. Carlson

Drake University: Des Moines, IA, US

2010-08-23 to 2016-05-13 | PharmD
Education
Source: Self-asserted source
Travis J. Carlson

Works (28)

Quantifying antimicrobial disposals at six community pharmacies with longitudinal medication disposal programs: an underappreciated component of a One Health approach to antimicrobial stewardship

2025-02-03 | Other
DOI: 10.1093/ofid/ofaf040
Contributors: Travis J. Carlson; Elizabeth Hoskins; Elizabeth Bickenbach; Margaret Buchanan; Steve Detter; Michael Ferguson; Ahunna Freeman; Ryan Hoskins; Aaron Johnston; Robbin Lee et al.
Source: check_circle
Crossref

The effect of a plasma next-generation sequencing test on antimicrobial management in immunocompetent and immunocompromised patients—A single-center retrospective study

Antimicrobial Stewardship & Healthcare Epidemiology
2023 | Journal article
DOI: 10.1017/ash.2022.356
Contributors: Denise Marie A. Francisco; Laila Woc-Colburn; Travis J. Carlson; Todd Lasco; Miriam Barrett; Mayar Al Mohajer
Source: check_circle
Crossref

Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategies

Gut Microbes
2023-12-31 | Journal article
DOI: 10.1080/19490976.2023.2223345
Contributors: Anne J. Gonzales-Luna; Travis J. Carlson; Kevin W. Garey
Source: check_circle
Crossref

Emerging Options for the Prevention and Management of Clostridioides difficile Infection

Drugs
2023-02 | Journal article
DOI: 10.1007/s40265-022-01832-x
Contributors: Anne J. Gonzales-Luna; Travis J. Carlson; Kevin W. Garey
Source: check_circle
Crossref

Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA

JAC-Antimicrobial Resistance
2022-12-29 | Journal article
DOI: 10.1093/jacamr/dlac131
Contributors: Truc T Tran; Nicolo L Cabrera; Anne J Gonzales-Luna; Travis J Carlson; Faris Alnezary; William R Miller; Aki Sakurai; An Q Dinh; Kirsten Rydell; Rafael Rios et al.
Source: check_circle
Crossref

National Disparities in Antibiotic Prescribing by Race, Ethnicity, Age Group, and Sex in United States Ambulatory Care Visits, 2009 to 2016

Antibiotics
2022-12-28 | Journal article
DOI: 10.3390/antibiotics12010051
Contributors: Eric H. Young; Kelsey A. Strey; Grace C. Lee; Travis J. Carlson; Jim M. Koeller; Vidal M. Mendoza; Kelly R. Reveles
Source: check_circle
Crossref

Clostridioides difficile Infection Treatment and Outcome Disparities in a National Sample of United States Hospitals

Antibiotics
2022-09-06 | Journal article
DOI: 10.3390/antibiotics11091203
Contributors: Eric H. Young; Kelsey A. Strey; Grace C. Lee; Travis J. Carlson; Jim M. Koeller; Kelly R. Reveles
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection.

Seminars in respiratory and critical care medicine
2022-02-16 | Journal article
DOI: 10.1055/s-0041-1740973
PMID: 35172356
Contributors: Carlson TJ; Gonzales-Luna AJ; Garey KW
Source: Self-asserted source
Travis J. Carlson

Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections

Open Forum Infectious Diseases
2021-12-01 | Journal article
DOI: 10.1093/ofid/ofab554
Contributors: Nicholas Rebold; Taylor Morrisette; Abdalhamid M Lagnf; Sara Alosaimy; Dana Holger; Katie Barber; Julie Ann Justo; Kayla Antosz; Travis J Carlson; Jeremy J Frens et al.
Source: check_circle
Crossref

Antibiotic Therapies for Clostridioides difficile Infection in Children

Journal of the Pediatric Infectious Diseases Society
2021-11-17 | Journal article
DOI: 10.1093/jpids/piab059
Contributors: Anne J Gonzales-Luna; Travis J Carlson; Kevin W Garey
Source: check_circle
Crossref

Corticosteroids Do Not Increase the Likelihood of Primary Clostridioides difficile Infection in the Setting of Broad-Spectrum Antibiotic Use

Open Forum Infectious Diseases
2021-10-01 | Journal article
DOI: 10.1093/ofid/ofab419
Contributors: Travis J Carlson; Anne J Gonzales-Luna; Melissa F Wilcox; Sarah G Theriault; Faris S Alnezary; Pankaj Patel; Bumhee K Ahn; Evan J Zasowski; Kevin W Garey
Source: check_circle
Crossref

Challenges in Drug Discovery for Intracellular Bacteria

Pathogens
2021-09-11 | Journal article
DOI: 10.3390/pathogens10091172
Contributors: Allison N. Tucker; Travis J. Carlson; Aurijit Sarkar
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa

Open Forum Infectious Diseases
2021-08-01 | Journal article
DOI: 10.1093/ofid/ofab371
Contributors: Sara Alosaimy; Abdalhamid M Lagnf; Taylor Morrisette; Marco R Scipione; Jing J Zhao; Sarah C J Jorgensen; Ryan Mynatt; Travis J Carlson; Jinhee Jo; Kevin W Garey et al.
Source: check_circle
Crossref

Reduced Susceptibility to Metronidazole Is Associated With Initial Clinical Failure in <i>Clostridioides difficile</i> Infection.

Open forum infectious diseases
2021-07-08 | Journal article
DOI: 10.1093/ofid/ofab365
PMID: 34381844
PMC: PMC8351808
Contributors: Gonzales-Luna AJ; Olaitan AO; Shen WJ; Aditi Deshpande; Carlson TJ; Dotson KM; Lancaster C; Begum K; Alam MJ; Hurdle JG et al.
Source: Self-asserted source
Travis J. Carlson

Recent developments in antimicrobial therapy for gastrointestinal infections.

Current opinion in gastroenterology
2021-01-01 | Journal article
DOI: 10.1097/mog.0000000000000696
PMID: 33229860
Contributors: Carlson TJ; Gonzales-Luna AJ; Garey KW
Source: Self-asserted source
Travis J. Carlson

Clostridioides difficile ribotype 106: A systematic review of the antimicrobial susceptibility, genetics, and clinical outcomes of this common worldwide strain

Anaerobe
2020 | Journal article
DOI: 10.1016/j.anaerobe.2019.102142
EID:

2-s2.0-85078674915

Part of ISBN:

10958274 10759964
Contributors: Carlson, T.J.; Blasingame, D.; Gonzales-Luna, A.J.; Alnezary, F.; Garey, K.W.
Source: Self-asserted source
Travis J. Carlson via Scopus - Elsevier

Eosinopenia and binary toxin increase mortality in hospitalized patients with Clostridioides difficile infection

Open Forum Infectious Diseases
2020 | Journal article
DOI: 10.1093/ofid/ofz552
EID:

2-s2.0-85083053390

Part of ISBN:

23288957
Contributors: Carlson, T.J.; Endres, B.T.; Le Pham, J.; Gonzales-Luna, A.J.; Alnezary, F.S.; Nebo, K.; Miranda, J.; Lancaster, C.; Bassères, E.; Begum, K. et al.
Source: Self-asserted source
Travis J. Carlson via Scopus - Elsevier

Letter to the editor

Clinical Infectious Diseases
2020 | Journal article
DOI: 10.1093/cid/ciz426
EID:

2-s2.0-85077403736

Part of ISBN:

15376591 10584838
Contributors: Gonzales-Luna, A.J.; Carlson, T.J.
Source: Self-asserted source
Travis J. Carlson via Scopus - Elsevier

PCR ribotypes of Clostridioides difficile across Texas from 2011 to 2018 including emergence of ribotype 255

Emerging Microbes and Infections
2020 | Journal article
DOI: 10.1080/22221751.2020.1721335
EID:

2-s2.0-85079105980

Part of ISBN:

22221751
Contributors: Gonzales-Luna, A.J.; Carlson, T.J.; Dotson, K.M.; Poblete, K.; Costa, G.; Miranda, J.; Lancaster, C.; Walk, S.T.; Tupy, S.; Begum, K. et al.
Source: Self-asserted source
Travis J. Carlson via Scopus - Elsevier

Assessment of Kidney Injury as a Severity Criteria for <i>Clostridioides Difficile</i> Infection.

Open forum infectious diseases
2020-10-07 | Journal article
DOI: 10.1093/ofid/ofaa476
PMID: 33209956
PMC: PMC7652094
Contributors: Carlson TJ; Gonzales-Luna AJ; Nebo K; Chan HY; Tran NT; Antony S; Lancaster C; Alam MJ; Begum K; Kevin Garey
Source: Self-asserted source
Travis J. Carlson

In vitro activity of eravacycline against common ribotypes of Clostridioides difficile

Journal of Antimicrobial Chemotherapy
2020-10-01 | Journal article
DOI: 10.1093/jac/dkaa289
Contributors: Eugénie Bassères; Khurshida Begum; Chris Lancaster; Anne J Gonzales-Luna; Travis J Carlson; Julie Miranda; Tasnuva Rashid; M Jahangir Alam; David W Eyre; Mark H Wilcox et al.
Source: check_circle
Crossref

Utilizing antibiotics to prevent Clostridioides difficile infection: does exposure to a risk factor decrease risk? A systematic review

Journal of Antimicrobial Chemotherapy
2020-10-01 | Journal article
DOI: 10.1093/jac/dkaa251
Contributors: Travis J Carlson; Anne J Gonzales-Luna
Source: check_circle
Crossref

Antibiotic Treatment Pipeline for Clostridioides difficile Infection (CDI): A Wide Array of Narrow-Spectrum Agents

Current Infectious Disease Reports
2020-08 | Journal article
DOI: 10.1007/s11908-020-00730-1
Contributors: T. J. Carlson; A. J. Gonzales-Luna
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Follow your Gut: Microbiome-Based Approaches in the Developmental Pipeline for the Prevention and Adjunctive Treatment of Clostridioides difficile Infection (CDI)

Current Infectious Disease Reports
2020-08 | Journal article
DOI: 10.1007/s11908-020-00729-8
Part of ISSN: 1523-3847
Part of ISSN: 1534-3146
Contributors: Anne Gonzales-Luna; T. J. Carlson
Source: Self-asserted source
Travis J. Carlson

In Vitro Activity of Omadacycline, a New Tetracycline Analog, and Comparators against Clostridioides difficile.

Antimicrobial agents and chemotherapy
2020-07-22 | Journal article
DOI: 10.1128/aac.00522-20
PMID: 32513796
PMC: PMC7526832
Contributors: Begum K; Bassères E; Miranda J; Lancaster C; Gonzales-Luna AJ; Carlson TJ; Rashid T; David Eyre; Wilcox MH; Alam MJ et al.
Source: Self-asserted source
Travis J. Carlson

Real-world Multicenter Analysis of Clinical Outcomes and Safety of Meropenem-Vaborbactam in Patients Treated for Serious Gram-Negative Bacterial Infections.

Open forum infectious diseases
2020-02-19 | Journal article
DOI: 10.1093/ofid/ofaa051
PMID: 32161775
PMC: PMC7060146
Contributors: Alosaimy S; Jorgensen SCJ; Lagnf AM; Melvin S; Mynatt RP; Carlson TJ; Garey KW; Allen D; Venugopalan V; Veve M et al.
Source: Self-asserted source
Travis J. Carlson

Ridinilazole for the treatment of Clostridioides difficile infection

Expert Opinion on Investigational Drugs
2019 | Journal article
DOI: 10.1080/13543784.2019.1582640
EID:

2-s2.0-85062339372

Part of ISBN:

17447658 13543784
Contributors: Carlson, T.J.; Endres, B.T.; Bassères, E.; Gonzales-Luna, A.J.; Garey, K.W.
Source: Self-asserted source
Travis J. Carlson via Scopus - Elsevier

Significant Publications on Infectious Diseases Pharmacotherapy in 2018

Journal of Pharmacy Practice
2019 | Journal article
DOI: 10.1177/0897190019863921
EID:

2-s2.0-85070288479

Part of ISBN:

15311937 08971900
Contributors: Borjan, J.; Gonzales-Luna, A.J.; Carlson, T.J.; Finch, N.A.; Mitchell, A.P.; McDaneld, P.M.; Phe, K.; Foolad, F.
Source: Self-asserted source
Travis J. Carlson via Scopus - Elsevier

Peer review (5 reviews for 1 publication/grant)

Review activity for Open forum infectious diseases. (5)
How many people are using ORCID?